Pure Global

cobas HCV - Taiwan Registration 67e6cfcefff80f32249465d3c7e56542

Access comprehensive regulatory information for cobas HCV in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 67e6cfcefff80f32249465d3c7e56542 and manufactured by Roche Molecular Systems, Inc.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
67e6cfcefff80f32249465d3c7e56542
Registration Details
Taiwan FDA Registration: 67e6cfcefff80f32249465d3c7e56542
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

cobas HCV
TW: ็พ…ๆฐๅฏ้œธๆ–ฏๅ…จ่‡ชๅ‹•Cๅž‹่‚็‚Ž็—…ๆฏ’้‡ๆ ธ้…ธๆชข้ฉ—็ต„
Risk Class 3
MD

Registration Details

67e6cfcefff80f32249465d3c7e56542

Ministry of Health Medical Device Import No. 030547

DHA05603054704

Company Information

United States

Product Details

This product is an in vitro nucleic acid amplified diagnostic reagent for the detection and quantification of HCV RNA in EDTA plasma or serum of HCV-infected individuals, genotypes 1 to 6.

B Hematology and pathology devices

B4020 Analyze specific reagents

Imported from abroad

Dates and Status

Apr 26, 2018

Apr 26, 2028